These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2937 related articles for article (PubMed ID: 21258394)

  • 21. Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor.
    Gupta S; Singh AK; Prajapati KS; Kushwaha PP; Shuaib M; Kumar S
    Cancer Lett; 2020 Jul; 483():22-34. PubMed ID: 32348807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and functional role of negative signalling regulators in tumour development and progression.
    Murphy T; Hori S; Sewell J; Gnanapragasam VJ
    Int J Cancer; 2010 Dec; 127(11):2491-9. PubMed ID: 20607827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting GLI Transcription Factors in Cancer.
    Didiasova M; Schaefer L; Wygrecka M
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.
    Hollander D; Donyo M; Atias N; Mekahel K; Melamed Z; Yannai S; Lev-Maor G; Shilo A; Schwartz S; Barshack I; Sharan R; Ast G
    Genome Res; 2016 Apr; 26(4):541-53. PubMed ID: 26860615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
    Luk IY; Reehorst CM; Mariadason JM
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-related networks: a help to understand, predict and change malignant transformation.
    Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer biology and Mr. Darwin.
    Gatenby R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):67-68. PubMed ID: 28412279
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro transformation models: modeling human cancer.
    Heeg S; Doebele M; von Werder A; Opitz OG
    Cell Cycle; 2006 Mar; 5(6):630-4. PubMed ID: 16582608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination.
    Pruitt HC; Devine DJ; Samant RS
    Int J Cancer; 2016 Aug; 139(3):491-500. PubMed ID: 26874464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
    Gatenby RA; Brown J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of YAP/TAZ activity in cancer metabolic reprogramming.
    Zhang X; Zhao H; Li Y; Xia D; Yang L; Ma Y; Li H
    Mol Cancer; 2018 Sep; 17(1):134. PubMed ID: 30176928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis.
    Malysheva V; Mendoza-Parra MA; Saleem MA; Gronemeyer H
    Genome Med; 2016 May; 8(1):57. PubMed ID: 27198694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The duality of human oncoproteins: drivers of cancer and congenital disorders.
    Castel P; Rauen KA; McCormick F
    Nat Rev Cancer; 2020 Jul; 20(7):383-397. PubMed ID: 32341551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondria: The metabolic switch of cellular oncogenic transformation.
    Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAS-mediated oncogenic signaling pathways in human malignancies.
    Khan AQ; Kuttikrishnan S; Siveen KS; Prabhu KS; Shanmugakonar M; Al-Naemi HA; Haris M; Dermime S; Uddin S
    Semin Cancer Biol; 2019 Feb; 54():1-13. PubMed ID: 29524560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis.
    Chevet E; Hetz C; Samali A
    Cancer Discov; 2015 Jun; 5(6):586-97. PubMed ID: 25977222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation.
    Yokoyama T; Nakamura T
    Cancer Sci; 2011 Jun; 102(6):1115-22. PubMed ID: 21338441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1.
    Janse van Rensburg HJ; Lai D; Azad T; Hao Y; Yang X
    Cell Signal; 2018 Dec; 52():12-22. PubMed ID: 30138697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 147.